CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Shortened Drug Regimens for the Treatment of Active Tuberculosis: Clinical Effectiveness

Last updated: August 31, 2020
Project Number: RB1515-000
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of shortened drug regimens for the treatment of active tuberculosis?

Key Message

One systematic review and one randomized controlled trial were identified regarding the clinical effectiveness of shortened drug regimens for the treatment of active tuberculosis.